Search - tctmd.com

Displaying 101 - 120 of 132

Sort: Relevancy | Date

News Conference News TCT 2014

EVERBIO II: Angiographic Outcomes Similar for BVS, EES, BES

September 17, 2014

News Conference News TCT 2014

CANARY: Lipid Plaque Burden May Indicate Risk for Periprocedural Myonecrosis

September 14, 2014

News Conference News TCT 2014

Post-PCI STEMI Infarct Size Strong Predictor of Mortality, Rehospitalization

September 14, 2014

News Conference News TCT 2014

Experts Debate Future of Renal Denervation Therapy

September 13, 2014

News Conference News TCT 2013

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

November 03, 2013

Presentation TCT 2013

The Common Dilemma of Managing Operator Learning Curve Issues and Evolving Clinical Trial Considerations (eg, Control Populations, Clinical Indications, and Optimal Endpoints)

Presenter: Ted Feldman

October 30, 2013

Presentation TCT 2013

Optimal Management of Multivessel Disease in Patients Undergoing Primary PCI: Design and Rationale of the Multinational COMPLETE Trial

Presenter: Shamir Mehta

October 30, 2013

News Conference News TCT 2013

Two Studies Examine Two-Stent Strategy vs. Provisional Stenting in Coronary Bifurcation Lesions

October 30, 2013

News Conference News TCT 2013

Novel Ischemia Measurement Strategies Show Potential vs. FFR

October 30, 2013

News Conference News TCT 2013

SYNTAX Cost-effectiveness Analysis Supports Existing Guidelines

October 29, 2013

News Conference News TCT 2013

State of the Stent: PCI Future Intact Despite Costs, Sociopolitical Factors

October 29, 2013

News Conference News TCT 2013

Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease

October 29, 2013

News Conference News TCT 2012

ETAP Trial: Nitinol Stent Bests Angioplasty for Popliteal Artery Disease

November 18, 2012

News Conference News TCT 2012

PARTNER: Benefits of TAVR Sustained Out to 3 Years

October 25, 2012

News Conference News TCT 2012

Experts Discuss Future of Renal Denervation

October 25, 2012

News Conference News TCT 2012

Paradigm Shift from Ischemia to Vulnerable Plaque Needed to Prevent Sudden Coronary Death

October 24, 2012

News Conference News TCT 2012

Promising Outlook for Bioabsorbable Scaffolds, Polymers in Next-Generation Stents

October 24, 2012

Presentation TCT 2012

TCT-43. Final Five-year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients with Three-vessel Disease

Presenter: A. Pieter Kappetein

October 23, 2012

News Conference News TCT 2012

VERDICT/F1RST Confirms Modest Correlation Between IVUS, MLA and FFR

October 23, 2012

News Conference News TCT 2012

New Results from SYNTAX, SPIRIT Trials Presented

October 22, 2012

Advertisement

EVERBIO II: Angiographic Outcomes Similar for BVS, EES, BES

CANARY: Lipid Plaque Burden May Indicate Risk for Periprocedural Myonecrosis

Post-PCI STEMI Infarct Size Strong Predictor of Mortality, Rehospitalization

Experts Debate Future of Renal Denervation Therapy

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

The Common Dilemma of Managing Operator Learning Curve Issues and Evolving Clinical Trial Considerations (eg, Control Populations, Clinical Indications, and Optimal Endpoints)

Optimal Management of Multivessel Disease in Patients Undergoing Primary PCI: Design and Rationale of the Multinational COMPLETE Trial

Two Studies Examine Two-Stent Strategy vs. Provisional Stenting in Coronary Bifurcation Lesions

Novel Ischemia Measurement Strategies Show Potential vs. FFR

SYNTAX Cost-effectiveness Analysis Supports Existing Guidelines

State of the Stent: PCI Future Intact Despite Costs, Sociopolitical Factors

Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease

ETAP Trial: Nitinol Stent Bests Angioplasty for Popliteal Artery Disease

PARTNER: Benefits of TAVR Sustained Out to 3 Years

Experts Discuss Future of Renal Denervation

Paradigm Shift from Ischemia to Vulnerable Plaque Needed to Prevent Sudden Coronary Death

Promising Outlook for Bioabsorbable Scaffolds, Polymers in Next-Generation Stents

TCT-43. Final Five-year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients with Three-vessel Disease

VERDICT/F1RST Confirms Modest Correlation Between IVUS, MLA and FFR

New Results from SYNTAX, SPIRIT Trials Presented

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content